Kedalion Capital Management LLP

LONDON, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$4.24B2026 Q3+ $51.1M options (notional, not included)
Positions5
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Kedalion Capital Management LLP reported 5 positions worth $4.24B as of September 30, 2026 (13F filed November 6, 2026). Largest holding: SPYM (94.2%). Biggest move: reduce IVV ($943.5M).

5 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SPYMSPDR Series$4.04B94.15%44,970,000———
▸ 2 IVVIshares Tr$199.1M4.64%260,000———
▸ 3 LQDCallIshares Tr$51.1M notional1.19%500,000———
▸ 4 WBDWarner Bros. Discovery$508.4K0.01%16,427——0.0%
▸ 5 ABUSArbutus Biopharma$96.4K0.00%20,168——-14.4%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Kedalion Capital Management LLP hold as of Q3 2026?

Kedalion Capital Management LLP reported 5 positions worth $4.24B in its Q3 2026 13F filing. Largest positions: SPYM (94.2%), IVV (4.6%), LQD (1.2%), WBD (0.0%) and ABUS (0.0%).

What did Kedalion Capital Management LLP buy in Q3 2026?

New positions: LQD, WBD and ABUS. Added to: SPYM.

What did Kedalion Capital Management LLP sell in Q3 2026?

Reduced: IVV. Sold out entirely: BE.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.